EE05507B1 - Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks - Google Patents

Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks

Info

Publication number
EE05507B1
EE05507B1 EEP200300239A EEP200300239A EE05507B1 EE 05507 B1 EE05507 B1 EE 05507B1 EE P200300239 A EEP200300239 A EE P200300239A EE P200300239 A EEP200300239 A EE P200300239A EE 05507 B1 EE05507 B1 EE 05507B1
Authority
EE
Estonia
Prior art keywords
percolesterolemia
heterosgococcal
rosuvastatin
family
treatment
Prior art date
Application number
EEP200300239A
Other languages
English (en)
Estonian (et)
Inventor
Ali@Raza
Howard@Gerard@Hutchinson
Original Assignee
AstraZeneca@AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9903629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05507(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AstraZeneca@AB filed Critical AstraZeneca@AB
Publication of EE200300239A publication Critical patent/EE200300239A/xx
Publication of EE05507B1 publication Critical patent/EE05507B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200300239A 2000-11-22 2001-11-16 Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks EE05507B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0028429.9A GB0028429D0 (en) 2000-11-22 2000-11-22 Therapy
PCT/GB2001/005041 WO2002041895A1 (en) 2000-11-22 2001-11-16 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia

Publications (2)

Publication Number Publication Date
EE200300239A EE200300239A (et) 2003-08-15
EE05507B1 true EE05507B1 (et) 2012-02-15

Family

ID=9903629

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300239A EE05507B1 (et) 2000-11-22 2001-11-16 Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks

Country Status (34)

Country Link
US (1) US6858618B2 (OSRAM)
EP (1) EP1339409B1 (OSRAM)
JP (2) JP5062940B2 (OSRAM)
KR (1) KR100815042B1 (OSRAM)
CN (1) CN1268339C (OSRAM)
AR (1) AR031766A1 (OSRAM)
AT (1) ATE394103T1 (OSRAM)
AU (2) AU2002214165B9 (OSRAM)
BG (1) BG66009B1 (OSRAM)
BR (1) BR0115511A (OSRAM)
CA (1) CA2429263C (OSRAM)
CY (1) CY1110428T1 (OSRAM)
CZ (1) CZ301583B6 (OSRAM)
DE (1) DE60133921D1 (OSRAM)
DK (1) DK1339409T3 (OSRAM)
EE (1) EE05507B1 (OSRAM)
ES (1) ES2305118T3 (OSRAM)
GB (1) GB0028429D0 (OSRAM)
HU (1) HUP0301380A3 (OSRAM)
IL (2) IL155919A0 (OSRAM)
IS (1) IS6819A (OSRAM)
MX (1) MXPA03004336A (OSRAM)
MY (1) MY134902A (OSRAM)
NO (1) NO326245B1 (OSRAM)
NZ (1) NZ525754A (OSRAM)
PL (1) PL365386A1 (OSRAM)
PT (1) PT1339409E (OSRAM)
RU (1) RU2294744C2 (OSRAM)
SI (1) SI1339409T1 (OSRAM)
SK (1) SK6212003A3 (OSRAM)
TW (1) TWI238720B (OSRAM)
UA (1) UA75614C2 (OSRAM)
WO (1) WO2002041895A1 (OSRAM)
ZA (1) ZA200303636B (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003305D0 (en) * 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
US7407965B2 (en) * 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
US20050261237A1 (en) * 2003-04-25 2005-11-24 Boojamra Constantine G Nucleoside phosphonate analogs
US7452901B2 (en) * 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
EP1628685B1 (en) 2003-04-25 2010-12-08 Gilead Sciences, Inc. Antiviral phosphonate analogs
US7470724B2 (en) * 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
US20090247488A1 (en) * 2003-04-25 2009-10-01 Carina Cannizzaro Anti-inflammatory phosphonate compounds
MXPA05011296A (es) * 2003-04-25 2006-01-24 Gilead Sciences Inc Conjugados de fosfonato inhibidores de la cinasa.
WO2005023778A2 (en) * 2003-08-28 2005-03-17 Teva Pharmaceutical Industries Ltd. Process for preparation of rosuvastatin calcium
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
US7432273B2 (en) * 2003-10-24 2008-10-07 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
US7777034B2 (en) 2003-11-24 2010-08-17 Teva Pharmaceutical Industries Ltd. Crystalline ammonium salts of rosuvastatin
EP1689723B1 (en) * 2003-12-02 2011-04-27 Teva Pharmaceutical Industries, Ltd. Reference standard for characterization of rosuvastatin
US20070179166A1 (en) * 2003-12-24 2007-08-02 Valerie Niddam-Hildesheim Process for preparation of statins with high syn to anti ratio
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
US20060013861A1 (en) * 2004-05-26 2006-01-19 Kgk Synergize Inc. Functional foods comprising flavonoids and tocotrienols and methods thereof
EP1673351A1 (en) * 2004-07-13 2006-06-28 Teva Pharmaceutical Industries Ltd. A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step
WO2006110157A2 (en) 2004-07-27 2006-10-19 Gilead Sciences, Inc. Nucleoside phosphonate conjugates as anti hiv agents
CA2591439C (en) * 2005-02-22 2013-03-26 Teva Pharmaceutical Industries Ltd. Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
US20070037979A1 (en) * 2005-02-22 2007-02-15 Valerie Niddam-Hildesheim Preparation of rosuvastatin
US20070167625A1 (en) * 2005-02-22 2007-07-19 Anna Balanov Preparation of rosuvastatin
MX2007004427A (es) * 2005-08-16 2007-06-14 Teva Pharma Intermedio de rosuvastatina cristalina.
US8383614B2 (en) * 2008-01-31 2013-02-26 The Trustees Of The University Of Pennsylvania Hypercholestrolemia and tendinous injuries
US9427437B2 (en) 2008-01-31 2016-08-30 The Trustees Of The University Of Pennsylvania Hypercholesterolemia and tendinous injuries
WO2009143776A1 (zh) 2008-05-27 2009-12-03 常州制药厂有限公司 瑞舒伐他汀钙盐的制备方法及其中间体
HRP20120700T1 (hr) 2008-07-08 2012-09-30 Gilead Sciences SOLI SPOJEVA INHIBITORA HIV-a
AR092872A1 (es) 2012-09-17 2015-05-06 Madrigal Pharmaceuticals Inc Metodo para sintetizar analogos de la hormona tiroidea y polimorfos de los mismos
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
US10600502B2 (en) 2016-12-20 2020-03-24 Astrazeneca Uk Ltd. Systems and methods for dispensing a statin medication over the counter
ES2892402T3 (es) 2017-08-01 2022-02-04 Gilead Sciences Inc Formas cristalinas de ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-il)-4-fluoro-2,5-dihidrofuran-2-il)oxi)metil)(fenoxi)fosforil)-L-alaninato de etilo para tratar infecciones virales
PE20220164A1 (es) 2019-05-27 2022-01-28 Immatics Us Inc Vectores viricos y uso de los mismos en terapias celulares adoptivas
DE102020111571A1 (de) 2020-03-11 2021-09-16 Immatics US, Inc. Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
US20220008519A1 (en) 2020-07-09 2022-01-13 Costa Rican Social Security Fund / Caja Costarricense de Seguro Social (CCSS) Treatment of severe acute respiratory syndrome-related coronavirus infection with klotho
WO2022040631A1 (en) 2020-08-21 2022-02-24 Immatics US, Inc. Methods for isolating cd8+ selected t cells
JP2024506848A (ja) * 2021-02-01 2024-02-15 マドリガル ファーマシューティカルズ インコーポレイテッド 肝障害又は脂質障害の治療のためのロスバスタチンとレスメチロムの治療的組み合わせ
US12377104B1 (en) 2024-02-06 2025-08-05 Madrigal Pharmaceuticals, Inc. Methods for treating a fatty liver disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2051907C1 (ru) * 1989-05-22 1996-01-10 Сандос АГ Способ получения 7-замещенной гептен-6-овой кислоты
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US6369103B1 (en) * 1994-01-18 2002-04-09 Bristol-Myers Squibb Company Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
AU6294501A (en) * 2000-09-20 2002-04-02 Rtp Pharma Inc Spray drying process and compositions of fenofibrate

Also Published As

Publication number Publication date
AR031766A1 (es) 2003-10-01
ZA200303636B (en) 2004-08-12
BG107811A (bg) 2004-03-31
ATE394103T1 (de) 2008-05-15
EP1339409A1 (en) 2003-09-03
PT1339409E (pt) 2008-07-07
BG66009B1 (bg) 2010-10-29
NZ525754A (en) 2004-10-29
CY1110428T1 (el) 2015-04-29
NO20032292D0 (no) 2003-05-21
HUP0301380A3 (en) 2007-03-28
DE60133921D1 (de) 2008-06-19
DK1339409T3 (da) 2008-09-08
HK1056691A1 (en) 2004-02-27
CN1630520A (zh) 2005-06-22
SK6212003A3 (en) 2003-11-04
CZ301583B6 (cs) 2010-04-21
IL155919A0 (en) 2003-12-23
CZ20031406A3 (cs) 2003-09-17
WO2002041895A1 (en) 2002-05-30
JP5062940B2 (ja) 2012-10-31
IS6819A (is) 2003-05-19
NO20032292L (no) 2003-07-17
GB0028429D0 (en) 2001-01-10
KR100815042B1 (ko) 2008-03-18
MY134902A (en) 2007-12-31
AU1416502A (en) 2002-06-03
AU2002214165B9 (en) 2013-07-04
EP1339409B1 (en) 2008-05-07
MXPA03004336A (es) 2003-08-19
UA75614C2 (uk) 2006-05-15
US6858618B2 (en) 2005-02-22
TWI238720B (en) 2005-09-01
JP2010031047A (ja) 2010-02-12
US20040072852A1 (en) 2004-04-15
HUP0301380A2 (hu) 2003-10-28
EE200300239A (et) 2003-08-15
BR0115511A (pt) 2003-12-30
KR20030048479A (ko) 2003-06-19
PL365386A1 (en) 2005-01-10
CN1268339C (zh) 2006-08-09
RU2294744C2 (ru) 2007-03-10
SI1339409T1 (sl) 2008-08-31
IL155919A (en) 2009-09-01
CA2429263C (en) 2009-03-17
ES2305118T3 (es) 2008-11-01
JP2004522714A (ja) 2004-07-29
AU2002214165B2 (en) 2006-12-14
NO326245B1 (no) 2008-10-27
CA2429263A1 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
ID30590A (id) Celana sekali pakai jenis-celana pendek
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
EE05073B1 (et) Retigabiin kasutamiseks neuropaatilise valu ravis
NO20024099D0 (no) Lavdose entecavir-formulering og anvendelse
DK1604680T3 (da) Anvendelse af butulinumtoksin ved behandlingen af neuralgisk smerte
NO20040469L (no) Heterocykliske forbindelser samt fremstilling og anvendelse derav
EE200300485A (et) Tiohüdantoinid ja nende kasutamine diabeedi raviks
DE50112013D1 (de) Deodorantien und antiperspirantien
AR027945A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
NO20034159D0 (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
EE200200571A (et) Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
IS6918A (is) Meðferð erfiðra æxla með notkun epóþílon afleiða
NO20032122L (no) Forbedret behandling
PL356784A1 (pl) Substancja do zastosowania w leczeniu łuszczycy
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
ID25571A (id) Popok sekali pakai
ID24782A (id) Popok sekali pakai
AU9279601A (en) Compounds and methods for use thereof in the treatment of cancer or viral infections
NO20041968L (no) Anvendelse av cystationin
IS7166A (is) Notkun annellataðra pýrrólsambanda í meðhöndlun áliðabrjósks- eða neðanbrjósksbeinahrörnun
EE200200577A (et) Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
EE200200479A (et) Eksemestaani kasutamine rinnavähi ravis
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer

Legal Events

Date Code Title Description
HD1A Correction of address
MM4A Lapsed by not paying the annual fees

Effective date: 20161116